Related Funds
Fund Name | Location |
Bankinter | Community of Madrid, Madrid, Spain |
Bramalea Partners | Boston, Massachusetts, United States |
Children's Health | Dallas, Texas, United States |
China Merchants Innovation Investment Management | - |
Clover Holdings Ltd | England, London, United Kingdom |
CM-CIC Innovation | France, Ile-de-France, Paris |
Financiere de Brienne | France, Ile-de-France, Paris |
HITO-Communications | Japan, Toshima |
Japan International Cooperation Agency | Chiyoda, Japan |
Kika Tech | California, San Jose, United States |
Lawson | Japan, Tokyo |
Miratech | Kyiv, Ukraine, Київська міська громада |
Ougui (Shanghai) Zichan Guanli Youxian Gongsi | China, Shanghai |
Second Generation LTD | Cleveland, Ohio, United States |
Sojitz | Japan, Tokyo |
SQFive Intelligent Oilfield Solutions | Alberta, Calgary, Canada |
The Nassau Group | Connecticut, United States, Westport |
The Refiners | California, San Francisco, United States |
Vaaka Partners | Finland, Helsinki, Southern Finland |
West Steag Partners | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MoleculeMind | 13 Sep 2024 | Haidian, Beijing, China | |||
ICleague Technology | 17 Jul 2024 | Shanghai, Shanghai, China | |||
EPICMEMS | 05 Jan 2024 | - | |||
MindRank AI | $23M | 18 Jul 2023 | Shanghai, Shanghai, China | ||
Enkang Pharmaceutical Technology | 23 Jan 2023 | Guangzhou, Guangdong, China | |||
PVmed | $14M | 22 Dec 2022 | Guangzhou, Guangdong, China | ||
Sinogen Biopharma | $10M | 23 May 2022 | Boston, Massachusetts, United States | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China | ||
Yuntian Semiconductor | 06 Dec 2021 | Xiamen, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MoleculeMind | 13 Sep 2024 | Haidian, Beijing, China | |||
ICleague Technology | 17 Jul 2024 | Shanghai, Shanghai, China | |||
EPICMEMS | 05 Jan 2024 | - | |||
MindRank AI | $23M | 18 Jul 2023 | Shanghai, Shanghai, China | ||
Enkang Pharmaceutical Technology | 23 Jan 2023 | Guangzhou, Guangdong, China | |||
PVmed | $14M | 22 Dec 2022 | Guangzhou, Guangdong, China | ||
Sinogen Biopharma | $10M | 23 May 2022 | Boston, Massachusetts, United States | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China | ||
Yuntian Semiconductor | 06 Dec 2021 | Xiamen, China |